142 related articles for article (PubMed ID: 37977148)
1. A longitudinal single-cell atlas of treatment response in pediatric AML.
Lambo S; Trinh DL; Ries RE; Jin D; Setiadi A; Ng M; Leblanc VG; Loken MR; Brodersen LE; Dai F; Pardo LM; Ma X; Vercauteren SM; Meshinchi S; Marra MA
Cancer Cell; 2023 Dec; 41(12):2117-2135.e12. PubMed ID: 37977148
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia.
Mumme HL; Raikar SS; Bhasin SS; Thomas BE; Lawrence T; Weinzierl EP; Pang Y; DeRyckere D; Gawad C; Wechsler DS; Porter CC; Castellino SM; Graham DK; Bhasin M
Genome Med; 2023 Oct; 15(1):83. PubMed ID: 37845689
[TBL] [Abstract][Full Text] [Related]
3. A single-cell survey of cellular hierarchy in acute myeloid leukemia.
Wu J; Xiao Y; Sun J; Sun H; Chen H; Zhu Y; Fu H; Yu C; E W; Lai S; Ma L; Li J; Fei L; Jiang M; Wang J; Ye F; Wang R; Zhou Z; Zhang G; Zhang T; Ding Q; Wang Z; Hao S; Liu L; Zheng W; He J; Huang W; Wang Y; Xie J; Li T; Cheng T; Han X; Huang H; Guo G
J Hematol Oncol; 2020 Sep; 13(1):128. PubMed ID: 32977829
[TBL] [Abstract][Full Text] [Related]
4. Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives.
Chianese U; Papulino C; Megchelenbrink W; Tambaro FP; Ciardiello F; Benedetti R; Altucci L
Semin Cancer Biol; 2023 Jul; 92():84-101. PubMed ID: 37003397
[TBL] [Abstract][Full Text] [Related]
5. Convergent epigenetic evolution drives relapse in acute myeloid leukemia.
Nuno K; Azizi A; Koehnke T; Lareau C; Ediriwickrema A; Corces MR; Satpathy AT; Majeti R
Elife; 2024 Apr; 13():. PubMed ID: 38647535
[TBL] [Abstract][Full Text] [Related]
6. Chemoresistance in acute myeloid leukemia: An alternative single-cell RNA sequencing approach.
Cheng PL; Hsiao TH; Chen CH; Hung MN; Jhan PP; Lee LW; Wu TS; Tsai JR; Teng CJ
Hematol Oncol; 2023 Aug; 41(3):499-509. PubMed ID: 36790759
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia.
Verboon LJ; Obulkasim A; de Rooij JD; Katsman-Kuipers JE; Sonneveld E; Baruchel A; Trka J; Reinhardt D; Pieters R; Cloos J; Kaspers GJ; Klusmann JH; Zwaan CM; Fornerod M; van den Heuvel-Eibrink MM
Oncotarget; 2016 Jul; 7(30):48412-48422. PubMed ID: 27351222
[TBL] [Abstract][Full Text] [Related]
8. Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance.
Fan H; Wang F; Zeng A; Murison A; Tomczak K; Hao D; Jelloul FZ; Wang B; Barrodia P; Liang S; Chen K; Wang L; Zhao Z; Rai K; Jain AK; Dick J; Daver N; Futreal A; Abbas HA
Commun Biol; 2023 Jul; 6(1):765. PubMed ID: 37479893
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment.
Peroni E; Randi ML; Rosato A; Cagnin S
J Exp Clin Cancer Res; 2023 Oct; 42(1):259. PubMed ID: 37803464
[TBL] [Abstract][Full Text] [Related]
10. Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy.
Kim D; Kim S; Song H; Gwak D; Min S; Byun JM; Koh Y; Hong J; Yoon SS; Yun H; Shin DY
Cancer Med; 2024 Apr; 13(7):e7182. PubMed ID: 38591109
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals RNA N6-methyladenosine modification associated with prognosis and drug resistance in acute myeloid leukemia.
Li Z; Liu X; Wang L; Zhao H; Wang S; Yu G; Wu D; Chu J; Han J
Front Immunol; 2023; 14():1281687. PubMed ID: 38022588
[TBL] [Abstract][Full Text] [Related]
12. Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity.
van Galen P; Hovestadt V; Wadsworth Ii MH; Hughes TK; Griffin GK; Battaglia S; Verga JA; Stephansky J; Pastika TJ; Lombardi Story J; Pinkus GS; Pozdnyakova O; Galinsky I; Stone RM; Graubert TA; Shalek AK; Aster JC; Lane AA; Bernstein BE
Cell; 2019 Mar; 176(6):1265-1281.e24. PubMed ID: 30827681
[TBL] [Abstract][Full Text] [Related]
13. CircRNF220, not its linear cognate gene RNF220, regulates cell growth and is associated with relapse in pediatric acute myeloid leukemia.
Liu X; Liu X; Cai M; Luo A; He Y; Liu S; Zhang X; Yang X; Xu L; Jiang H
Mol Cancer; 2021 Oct; 20(1):139. PubMed ID: 34702297
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia.
Zhai Y; Singh P; Dolnik A; Brazda P; Atlasy N; Del Gaudio N; Döhner K; Döhner H; Minucci S; Martens J; Altucci L; Megchelenbrink W; Bullinger L; Stunnenberg HG
Mol Cancer; 2022 Aug; 21(1):166. PubMed ID: 35986270
[TBL] [Abstract][Full Text] [Related]
15. Not the presence but the amount of clonal DNA detectable in remission of acute myeloid leukemia is predictive for relapse.
Reif SW; Wiesner D; Duell T; Mittermueller J; Schmetzer HM
Eur J Haematol; 2001 Oct; 67(4):207-20. PubMed ID: 11860441
[TBL] [Abstract][Full Text] [Related]
16. The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study.
Moritake H; Tanaka S; Miyamura T; Nakayama H; Shiba N; Shimada A; Terui K; Yuza Y; Koh K; Goto H; Kakuda H; Saito A; Hasegawa D; Iwamoto S; Taga T; Adachi S; Tomizawa D
Pediatr Blood Cancer; 2021 Jan; 68(1):e28736. PubMed ID: 32991072
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia.
Naldini MM; Casirati G; Barcella M; Rancoita PMV; Cosentino A; Caserta C; Pavesi F; Zonari E; Desantis G; Gilioli D; Carrabba MG; Vago L; Bernardi M; Di Micco R; Di Serio C; Merelli I; Volpin M; Montini E; Ciceri F; Gentner B
Nat Commun; 2023 Mar; 14(1):1285. PubMed ID: 36890137
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.
Thol F; Klesse S; Köhler L; Gabdoulline R; Kloos A; Liebich A; Wichmann M; Chaturvedi A; Fabisch J; Gaidzik VI; Paschka P; Bullinger L; Bug G; Serve H; Göhring G; Schlegelberger B; Lübbert M; Kirchner H; Wattad M; Kraemer D; Hertenstein B; Heil G; Fiedler W; Krauter J; Schlenk RF; Döhner K; Döhner H; Ganser A; Heuser M
Leukemia; 2017 Jun; 31(6):1286-1295. PubMed ID: 27881874
[TBL] [Abstract][Full Text] [Related]
19. Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets.
Stratmann S; Yones SA; Mayrhofer M; Norgren N; Skaftason A; Sun J; Smolinska K; Komorowski J; Herlin MK; Sundström C; Eriksson A; Höglund M; Palle J; Abrahamsson J; Jahnukainen K; Munthe-Kaas MC; Zeller B; Tamm KP; Cavelier L; Holmfeldt L
Blood Adv; 2021 Feb; 5(3):900-912. PubMed ID: 33560403
[TBL] [Abstract][Full Text] [Related]
20. Identification of Cell Type-Specific Effects of
Bae SG; Kim HJ; Kim MY; Kim DDH; Shin SI; Ahn JS; Park J
Mol Cells; 2023 Oct; 46(10):611-626. PubMed ID: 37853686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
